Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Catatonia and klüver-bucy syndrome in a patient with acute disseminated encephalomyelitis.
Clinical and cognitive implications of cerebrospinal fluid oligoclonal bands in multiple sclerosis patients.
Predicting relapsing-remitting dynamics in multiple sclerosis using discrete distribution models: a population approach.
Consistent reduction in the annualized rate of brain volume loss across phase 3 core and extension trials of fingolimod in relapsing multiple sclerosis.
Multiple sclerosis masquerading as Alzheimer-type dementia: Clinical, radiological and pathological findings.
[Visual neurorehabilitation of patients with cerebral damage using botulinum toxin].
Dramatically changing rates and reasons for hospitalization in multiple sclerosis.
High-intensity resistance training in multiple sclerosis - An exploratory study of effects on immune markers in blood and cerebrospinal fluid, and on mood, fatigue, health-related quality of life, muscle strength, walking and cognition.
There is much to be learnt about the costs of multiple sclerosis in Latin America.
Multiple sclerosis.
"Central vessel sign" on 3T FLAIR* MRI for the differentiation of multiple sclerosis from migraine.
Patterns in workplace accommodations for people with multiple sclerosis to overcome cognitive and other disease-related limitations.
Acute transverse myelitis in a child with lyme disease and a review of literature.
The effect of disease-modifying therapies on brain atrophy in patients with clinically isolated syndrome: a systematic review and meta-analysis.
[Remyelination strategy for multiple sclerosis].
Diagnosis of asymptomatic natalizumab-associated PML: are we between a rock and a hard place?
Commentary on: "Dirty-appearing white matter in multiple sclerosis: preliminary observations of myelin phospholipid and axonal loss", by G. R. W. Moore, et al. in J Neurol (2008) 255: DOI 10.1007/s00415-008-0002-z.
The PANGAEA study design - a prospective, multicenter, non-interventional, long-term study on fingolimod for the treatment of multiple sclerosis in daily practice.
Genital and sexual pain in women.
Bladder management in multiple sclerosis.
Lentivirus-Mediated RNA Interference Targeting RhoA Slacks the Migration, Proliferation, and Myelin Formation of Schwann Cells.
[New and future treatments for neurological disorders--knowledge essential to daily clinics and future prospects. Topics: 9. Therapeutic progress in multiple sclerosis and neuromyelitis optica].
Iron-based superparamagnetic nanoparticle contrast agents for MRI of infection and inflammation.
Translational utility of experimental autoimmune encephalomyelitis: recent developments.
A report from the American Academy of Neurology 2014 Annual Meeting (April 26-May 3 - Philadelphia, Pennsylvania, USA).

Pages